Katherine Byrd, Ph.D. - Publications

Affiliations: 
2015- Chemistry University of Kansas, Lawrence, KS, United States 
Website:
http://medchem.ku.edu/lucas-franco

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Merfeld T, Peng S, Keegan BM, Crowley VM, Brackett CM, Gutierrez A, McCann NR, Reynolds TS, Rhodes MC, Byrd KM, Deng J, Matts RL, Blagg BSJ. Elucidation of novel TRAP1-Selective inhibitors that regulate mitochondrial processes. European Journal of Medicinal Chemistry. 258: 115531. PMID 37307624 DOI: 10.1016/j.ejmech.2023.115531  0.476
2018 Byrd KM, Blagg BSJ. Chaperone substrate provides missing link for cancer drug discovery. The Journal of Biological Chemistry. 293: 2381-2382. PMID 29453286 DOI: 10.1074/jbc.H118.001591  0.466
2017 Byrd K, Kent C, Blagg B. Synthesis and biological evaluation of stilbene analogs as Hsp90 C-terminal inhibitors. Chemmedchem. PMID 29058824 DOI: 10.1002/cmdc.201700630  0.47
2016 Byrd KM, Subramanian C, Sanchez J, Motiwala HF, Liu W, Cohen MS, Holzbeierlein J, Blagg BS. Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 27037933 DOI: 10.1002/chem.201504955  0.484
2015 Byrd KM, Arieno MD, Kennelly ME, Estiu G, Wiest O, Helquist P. Design and synthesis of a crosslinker for studying intracellular steroid trafficking pathways. Bioorganic & Medicinal Chemistry. 23: 3843-51. PMID 25890696 DOI: 10.1016/J.Bmc.2015.03.053  0.412
2011 Cosner CC, Cabrera PJ, Byrd KM, Thomas AM, Helquist P. Selective oxidation of benzylic and allylic alcohols using Mn(OAc)3/catalytic 2,3-dichloro-5,6-dicyano-1,4-benzoquinone. Organic Letters. 13: 2071-3. PMID 21395252 DOI: 10.1021/Ol200441G  0.475
Show low-probability matches.